217 related articles for article (PubMed ID: 20185188)
1. Characterization of ribavirin uptake systems in human hepatocytes.
Fukuchi Y; Furihata T; Hashizume M; Iikura M; Chiba K
J Hepatol; 2010 Apr; 52(4):486-92. PubMed ID: 20185188
[TBL] [Abstract][Full Text] [Related]
2. Contribution of CNT1 and ENT1 to ribavirin uptake in human hepatocytes.
Choi MK; Kim MH; Maeng HJ; Song IS
Arch Pharm Res; 2015; 38(5):904-13. PubMed ID: 25011570
[TBL] [Abstract][Full Text] [Related]
3. Effect of thiazolidinediones on equilibrative nucleoside transporter-1 in human aortic smooth muscle cells.
Leung GP; Man RY; Tse CM
Biochem Pharmacol; 2005 Aug; 70(3):355-62. PubMed ID: 15963471
[TBL] [Abstract][Full Text] [Related]
4. Nucleoside transporter expression and function in cultured mouse astrocytes.
Peng L; Huang R; Yu AC; Fung KY; Rathbone MP; Hertz L
Glia; 2005 Oct; 52(1):25-35. PubMed ID: 15892125
[TBL] [Abstract][Full Text] [Related]
5. Equilibrative nucleoside transporter 1 expression in primary human hepatocytes is highly variable and determines uptake of ribavirin.
Baloch K; Chen L; Memon AA; Dexter L; Irving W; Ilyas M; Thomson BJ
Antivir Chem Chemother; 2017 Apr; 25(1):2-10. PubMed ID: 28417642
[TBL] [Abstract][Full Text] [Related]
6. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
[TBL] [Abstract][Full Text] [Related]
7. Quantification of ENT1 and ENT2 Proteins at the Placental Barrier and Contribution of These Transporters to Ribavirin Uptake.
Nishimura T; Sano Y; Takahashi Y; Noguchi S; Uchida Y; Takagi A; Tanaka T; Katakura S; Nakashima E; Tachikawa M; Maruyama T; Terasaki T; Tomi M
J Pharm Sci; 2019 Dec; 108(12):3917-3922. PubMed ID: 31520644
[TBL] [Abstract][Full Text] [Related]
8. Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes.
Govindarajan R; Endres CJ; Whittington D; LeCluyse E; Pastor-Anglada M; Tse CM; Unadkat JD
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G570-80. PubMed ID: 18635603
[TBL] [Abstract][Full Text] [Related]
9. Ribavirin ante portas: uptake transporters into hepatocytes dissected.
Bengsch B; Thimme R
J Hepatol; 2010 Apr; 52(4):469-71. PubMed ID: 20185189
[No Abstract] [Full Text] [Related]
10. Differential expression and regulation of nucleoside transport systems in rat liver parenchymal and hepatoma cells.
del Santo B; Valdés R; Mata J; Felipe A; Casado FJ; Pastor-Anglada M
Hepatology; 1998 Dec; 28(6):1504-11. PubMed ID: 9828213
[TBL] [Abstract][Full Text] [Related]
11. Ribavirin uptake by cultured human choriocarcinoma (BeWo) cells and Xenopus laevis oocytes expressing recombinant plasma membrane human nucleoside transporters.
Yamamoto T; Kuniki K; Takekuma Y; Hirano T; Iseki K; Sugawara M
Eur J Pharmacol; 2007 Feb; 557(1):1-8. PubMed ID: 17140564
[TBL] [Abstract][Full Text] [Related]
12. Fluorouracil uptake in triple-negative breast cancer cells: Negligible contribution of equilibrative nucleoside transporters 1 and 2.
Noguchi S; Takagi A; Tanaka T; Takahashi Y; Pan X; Kibayashi Y; Mizokami R; Nishimura T; Tomi M
Biopharm Drug Dispos; 2021 Mar; 42(2-3):85-93. PubMed ID: 33426680
[TBL] [Abstract][Full Text] [Related]
13. ENT1, a ribavirin transporter, plays a pivotal role in antiviral efficacy of ribavirin in a hepatitis C virus replication cell system.
Iikura M; Furihata T; Mizuguchi M; Nagai M; Ikeda M; Kato N; Tsubota A; Chiba K
Antimicrob Agents Chemother; 2012 Mar; 56(3):1407-13. PubMed ID: 22232287
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the concentrative nucleoside transporter 3 and equilibrative nucleoside transporter 2 in the resistance of T-lymphoblastic cell lines to thiopurines.
Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
Biochem Biophys Res Commun; 2006 Apr; 343(1):208-15. PubMed ID: 16530731
[TBL] [Abstract][Full Text] [Related]
15. Expression of equilibrative nucleoside transporter 1 in rat circumvallate papillae.
Nishida K; Kitada T; Kato J; Dohi Y; Nagasawa K
Neurosci Lett; 2013 Jan; 533():104-8. PubMed ID: 23147119
[TBL] [Abstract][Full Text] [Related]
16. Functional expression of equilibrative and concentrative nucleoside transporters in alveolar epithelial cells.
Baba S; Yumoto R; Kawami M; Takano M
Pharmazie; 2021 Sep; 76(9):416-421. PubMed ID: 34481531
[TBL] [Abstract][Full Text] [Related]
17. Equilibrative Nucleoside Transporter 1 (ENT1,
Cerveny L; Ptackova Z; Ceckova M; Karahoda R; Karbanova S; Jiraskova L; Greenwood SL; Glazier JD; Staud F
Drug Metab Dispos; 2018 Nov; 46(11):1817-1826. PubMed ID: 30097436
[TBL] [Abstract][Full Text] [Related]
18. Genomic organization and expression of the mouse equilibrative, nitrobenzylthioinosine-sensitive nucleoside transporter 1 (ENT1) gene.
Choi DS; Handa M; Young H; Gordon AS; Diamond I; Messing RO
Biochem Biophys Res Commun; 2000 Oct; 277(1):200-8. PubMed ID: 11027664
[TBL] [Abstract][Full Text] [Related]
19. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.
Miller SR; Hau RK; Jilek JL; Morales MN; Wright SH; Cherrington NJ
Drug Metab Dispos; 2020 Jul; 48(7):603-612. PubMed ID: 32393653
[TBL] [Abstract][Full Text] [Related]
20. High D-glucose reduces SLC29A1 promoter activity and adenosine transport involving specific protein 1 in human umbilical vein endothelium.
Puebla C; Farías M; González M; Vecchiola A; Aguayo C; Krause B; Pastor-Anglada M; Casanello P; Sobrevia L
J Cell Physiol; 2008 Jun; 215(3):645-56. PubMed ID: 18064606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
